Effect of Statins on the Risk of Poststroke Pneumonia: National Population-Based Cohort Study

References

• Armstrong JR, Mosher BD. Aspiration pneumonia after stroke: intervention and prevention. Neurohospitalist. 2011;1(2):85–93. doi:10.1177/194187521039577523983842
   PubMedGoogle Scholar
• LaCroix AZ, Lipson S, Miles TP, White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep. 1989;104(4):350–360.2502806
   PubMed Web of Science ®Google Scholar
• Salive ME, Satterfield S, Ostfeld AM, Wallace RB, Havlik RJ. Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adults. Public Health Rep. 1993;108(3):314–322.8497569
   PubMed Web of Science ®Google Scholar
• Wilson RD. Mortality and cost of pneumonia after stroke for different risk groups. J Stroke Cerebrovasc Dis. 2012;21(1):61–67. doi:10.1016/j.jstrokecerebrovasdis.2010.05.00222225864
   PubMed Web of Science ®Google Scholar
• Masiero S, Pierobon R, Previato C, Gomiero E. Pneumonia in stroke patients with oropharyngeal dysphagia: a six-month follow-up study. Neurol Sci. 2008;29(3):139–145. doi:10.1007/s10072-008-0925-218612760
   PubMed Web of Science ®Google Scholar
• Rocco A, Fam G, Sykora M, Diedler J, Nagel S, Ringleb P. Poststroke infections are an independent risk factor for poor functional outcome after three-months in thrombolysed stroke patients. Int J Stroke. 2013;8(8):639–644. doi:10.1111/j.1747-4949.2012.00822.x22631598
   PubMed Web of Science ®Google Scholar
• Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154(1):69–75. doi:10.1111/imm.1290229392731
   PubMed Web of Science ®Google Scholar
• Chopra V, Flanders SA. Statins and pneumonia. BMJ. 2011;342(apr06 2):d1907. doi:10.1136/bmj.d190721471176
   PubMed Web of Science ®Google Scholar
• Kwok CS, Yeong JK, Turner RM, Cavallazzi R, Singh S, Loke YK. Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies. Eur J Clin Pharmacol. 2012;68(5):747–755. doi:10.1007/s00228-011-1159-422083167
   PubMed Web of Science ®Google Scholar
• Scheitz JF, Endres M, Heuschmann PU, Audebert HJ, Nolte CH. Reduced risk of poststroke pneumonia in thrombolyzed stroke patients with continued statin treatment. Int J Stroke. 2015;10(1):61–66. doi:10.1111/j.1747-4949.2012.00864.x22973817
   PubMed Web of Science ®Google Scholar
• Rodriguez de Antonio LA, Martinez-Sanchez P, Martinez-Martinez MM, et al. Previous statins treatment and risk of post-stroke infections. Neurologia. 2011;26(3):150–156. doi:10.1016/j.nrl.2010.07.03021163226
   PubMed Web of Science ®Google Scholar
• Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46(2):e15. doi:10.1093/ije/dyw31726822938
   PubMed Web of Science ®Google Scholar
• Kim J, Lee HS, Nam CM, Heo JH. Effects of statin intensity and adherence on the long-term prognosis after acute ischemic stroke. Stroke. 2017;48(10):2723–2730. doi:10.1161/STROKEAHA.117.01814028916672
   PubMed Web of Science ®Google Scholar
• Franklin JM, Schneeweiss S. When and how can real world data analyses substitute for randomized controlled trials? Clin Pharmacol Ther. 2017;102(6):924–933. doi:10.1002/cpt.85728836267
   PubMed Web of Science ®Google Scholar
• Danaei G, Tavakkoli M, Hernan MA. Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol. 2012;175(4):250–262. doi:10.1093/aje/kwr30122223710
   PubMed Web of Science ®Google Scholar
• Song T-J, Kim J, Katsanos AH. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: a retrospective nationwide cohort study. PLoS One. 2019;14(5):e0216750. doi:10.1371/journal.pone.021675031067267
   PubMed Web of Science ®Google Scholar
• Davis RE, Dougherty E, McArthur C, Huang QS, Baker MG. Cold, dry air is associated with influenza and pneumonia mortality in Auckland, New Zealand. Influenza Other Respir Viruses. 2016;10(4):310–313. doi:10.1111/irv.1236926681638
   PubMed Web of Science ®Google Scholar
• Maniecka-Bryla I, Paciej-Golebiowska P, Dziankowska-Zaborszczyk E, Bryla M. Lost life years due to premature mortality caused by diseases of the respiratory system. Adv Clin Exp Med. 2018;27(6):743–748. doi:10.17219/acem/6922729877635
   PubMed Web of Science ®Google Scholar
• Azmi S, Aljunid SM, Maimaiti N, et al. Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines. Int J Infect Dis. 2016;49:87–93. doi:10.1016/j.ijid.2016.05.02127235085
   PubMed Web of Science ®Google Scholar
• Kim SA, Kilgore PE, Lee SY, Nyambat B, Ki M. Trends in pneumonia and influenza-associated hospitalizations in South Korea, 2002–2005. J Health Popul Nutr. 2011;29(6):574–582. doi:10.3329/jhpn.v29i6.989422283031
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1–S45. doi:10.1161/01.cir.0000437738.63853.7a24222016
   PubMed Web of Science ®Google Scholar
• Lee JH, Lim NK, Cho MC, Park HY. Epidemiology of heart failure in Korea: present and future. Korean Circ J. 2016;46(5):658–664. doi:10.4070/kcj.2016.46.5.65827721857
   PubMed Web of Science ®Google Scholar
• Kang YM, Kim YJ, Park JY, Lee WJ, Jung CH. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol. 2016;15(1):131. doi:10.1186/s12933-016-0451-027618811
   PubMed Web of Science ®Google Scholar
• Chang KC, Tseng MC, Weng HH, Lin YH, Liou CW, Tan TY. Prediction of length of stay of first-ever ischemic stroke. Stroke. 2002;33(11):2670–2674. doi:10.1161/01.STR.0000034396.68980.3912411659
   PubMed Web of Science ®Google Scholar
• Snapinn SM, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended kaplan-meier estimator. Am Stat. 2005;59(4):301–307. doi:10.1198/000313005X70371
   Web of Science ®Google Scholar
• Novack V, MacFadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM. The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. CMAJ. 2012;184(7):E367–E372. doi:10.1503/cmaj.11101722431901
   PubMed Web of Science ®Google Scholar
• Parihar SP, Guler R, Brombacher F. Statins: a viable candidate for host-directed therapy against infectious diseases. Nat Rev Immunol. 2019;19(2):104–117. doi:10.1038/s41577-018-0094-330487528
   PubMed Web of Science ®Google Scholar
• Bjorkhem-Bergman L, Bergman P, Andersson J, Lindh JD, Ratner AJ. Statin treatment and mortality in bacterial infections – a systematic review and meta-analysis. PLoS One. 2010;5(5):e10702. doi:10.1371/journal.pone.001070220502712
   PubMed Web of Science ®Google Scholar
• Shimabukuro-Vornhagen A, Liebig T, von Bergwelt-baildon M. Statins inhibit human APC function: implications for the treatment of GVHD. Blood. 2008;112(4):1544–1545. doi:10.1182/blood-2008-04-14960918684883
   PubMed Web of Science ®Google Scholar
• El-Achkar GA, Mrad MF, Mouawad CA, et al. Heme oxygenase-1-dependent anti-inflammatory effects of atorvastatin in zymosan-injected subcutaneous air pouch in mice. PLoS One. 2019;14(5):e0216405. doi:10.1371/journal.pone.021640531071151
   PubMed Web of Science ®Google Scholar
• Pruefer D, Makowski J, Schnell M, et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation. 2002;106(16):2104–2110. doi:10.1161/01.CIR.0000034048.38910.9112379581
   PubMed Web of Science ®Google Scholar
• Iwata A, Shirai R, Ishii H, et al. Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells. Clin Exp Immunol. 2012;168(2):234–240. doi:10.1111/j.1365-2249.2012.04564.x22471285
   PubMed Web of Science ®Google Scholar
• Wang XQ, Luo NS, Salah ZQ, Lin YQ, Gu MN, Chen YX. Atorvastatin attenuates TNF-alpha production via heme oxygenase-1 pathway in LPS-stimulated RAW264.7 macrophages. Biomed Environ Sci. 2014;27(10):786–793. doi:10.3967/bes2014.11425341814
   PubMed Web of Science ®Google Scholar
• Rahal EA, Constantin WN, Zeidan N, Abdelnoor AM. Atorvastatin reduces the survival of Candida albicans-infected BALB/c mice. Front Microbiol. 2015;6:1474. doi:10.3389/fmicb.2015.0147426732740
   PubMed Web of Science ®Google Scholar
• Blank N, Schiller M, Krienke S, et al. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis. J Immunol. 2007;179(6):3613–3621. doi:10.4049/jimmunol.179.6.361317785796
   PubMed Web of Science ®Google Scholar
• Brumeanu TD, Goldstein R, Casares S. Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors. Clin Immunol. 2006;119(1):1–12. doi:10.1016/j.clim.2005.11.00716386956
   PubMed Web of Science ®Google Scholar
• Kanda H, Yokota K, Kohno C, et al. Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios. Mod Rheumatol. 2007;17(5):364–368. doi:10.3109/s10165-007-0589-417929126
   PubMedGoogle Scholar
• Becker K, Tanzi P, Kalil A, Shibata D, Cain K. Early statin use is associated with increased risk of infection after stroke. J Stroke Cerebrovasc Dis. 2013;22(1):66–71. doi:10.1016/j.jstrokecerebrovasdis.2011.06.00821782466
   PubMed Web of Science ®Google Scholar
• Thurnher M, Nussbaumer O, Gruenbacher G. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin Cancer Res. 2012;18(13):3524–3531. doi:10.1158/1078-0432.CCR-12-048922529099
   PubMed Web of Science ®Google Scholar
• Walton GM, Stockley JA, Griffiths D, Sadhra CS, Purvis T, Sapey E. Repurposing treatments to enhance innate immunity. Can statins improve neutrophil functions and clinical outcomes in COPD?. J Clin Med. 2016;5(10):89. doi:10.3390/jcm5100089
   Web of Science ®Google Scholar
• Chow OA, von Kockritz-blickwede M, Bright AT, et al. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe. 2010;8(5):445–454. doi:10.1016/j.chom.2010.10.00521075355
   PubMed Web of Science ®Google Scholar
• Liao WC, Huang MZ, Wang ML, et al. Statin decreases helicobacter pylori burden in macrophages by promoting autophagy. Front Cell Infect Microbiol. 2016;6:203.28144585
   PubMed Web of Science ®Google Scholar
• Smith JD. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. J Clin Lipidol. 2010;4(5):382–388. doi:10.1016/j.jacl.2010.08.00721076633
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Grimes B, Dalrymple LS, et al. Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. J Clin Lipidol. 2018;12(2):481–487.e414. doi:10.1016/j.jacl.2017.12.00729361496
   PubMed Web of Science ®Google Scholar
• Ko HHT, Lareu RR, Dix BR, Hughes JD. In vitro antibacterial effects of statins against bacterial pathogens causing skin infections. Eur J Clin Microbiol Infect Dis. 2018;37(6):1125–1135. doi:10.1007/s10096-018-3227-529569046
   PubMed Web of Science ®Google Scholar
• Fedson DS. Treating influenza with statins and other immunomodulatory agents. Antiviral Res. 2013;99(3):417–435. doi:10.1016/j.antiviral.2013.06.01823831494
   PubMed Web of Science ®Google Scholar
• Tariq R, Mukhija D, Gupta A, Singh S, Pardi DS, Khanna S. Statin use and the risk of clostridium difficile infection: a systematic review with meta-analysis. Infect Drug Resist. 2018;11:405–416. doi:10.2147/IDR.S15647529559802
   PubMed Web of Science ®Google Scholar
• Xia DK, Hu ZG, Tian YF, Zeng FJ. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials. Drug Des Devel Ther. 2019;13:405–422. doi:10.2147/DDDT.S187690
   PubMed Web of Science ®Google Scholar
• Douglas I, Evans S, Smeeth L. Effect of statin treatment on short term mortality after pneumonia episode: cohort study. BMJ. 2011;342(apr06 2):d1642. doi:10.1136/bmj.d164221471172
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Syue SH, Lin CL, Hsu CY, Shae Z, Kao CH. Statin use and vital organ failure in patients with asthma-chronic obstructive pulmonary disease overlap: a Time-Dependent Population-Based Study. Front Pharmacol. 2019;10:889. doi:10.3389/fphar.2019.0088931474854
   PubMed Web of Science ®Google Scholar
• Huang CC, Chan WL, Chen YC, et al. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan. Clin Ther. 2011;33(10):1365–1370. doi:10.1016/j.clinthera.2011.08.01021962452
   PubMed Web of Science ®Google Scholar
• van den Hoek HL, Bos WJ, de Boer A, van de Garde EM. Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ. 2011;343(nov29 1):d7281. doi:10.1136/bmj.d728122127443
   PubMed Web of Science ®Google Scholar
• Lin S-P, Long Y-M, Chen X-H, Kirchmair R. The effects of statins on infections after stroke or transient ischemic attack: a meta-analysis. PLoS One. 2015;10(7):e0130071. doi:10.1371/journal.pone.013007126158560
   PubMed Web of Science ®Google Scholar
• Shin JY, Eberg M, Ernst P, Filion KB. Statin potency and the risk of hospitalization for community-acquired pneumonia. Br J Clin Pharmacol. 2017;83(6):1319–1327. doi:10.1111/bcp.1320827943383
   PubMed Web of Science ®Google Scholar
• Yende S, Milbrandt EB, Kellum JA, et al. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med. 2011;39(8):1871–1878. doi:10.1097/CCM.0b013e31821b829021516038
   PubMed Web of Science ®Google Scholar
• Kang J-H, Kao L-T, Lin H-C, Wang T-J, Yang T-Y, Aalto-Setala K. Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study. PLoS One. 2018;13(6):e0199981. doi:10.1371/journal.pone.019998129953536
   PubMed Web of Science ®Google Scholar
• van der Meij E, Koning GG, Vriens PW, et al. A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation. PLoS One. 2013;8(1):e53882. doi:10.1371/journal.pone.005388223349755
   PubMed Web of Science ®Google Scholar
• Lee JK, Grace KA, Foster TG, et al. How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag. 2007;3(4):685–690.18472991
   PubMedGoogle Scholar